HIV-controllers have the ability to spontaneously maintain viremia at low or undetectable levels in absence of antiretroviral treatment. Furthermore, HIV controllers seem to have superior capacity to spontaneously clear hepatitis C virus (HCV) coinfection compared to non HIV-controllers. Some of these subjects eventually lose HIV-controller status (transient controllers), in contrast with HIV-controllers with persistent natural HIV control (persistent controllers). It is unknown whether persistent controllers have superior capacity to spontaneously clear HCV coinfection compared to transient controllers.
HIV-controllers with available data for antibodies to HCV (anti-HCV) were recruited (n=744). Factors associated with HIV spontaneous control in relation to HCV coinfection were analyzed in persistent and transient HIV-controllers with anti-HCV positive (n=202 and n=138, respectively) in comparison with 1700 anti-HCV positive non HIV-controllers. In addition, the factors related to the loss and time to lose HIV-controller status were explored (n=744).
A higher frequency of HCV spontaneous clearance was found in persistent HIV-controllers (25.5%) compared to non-controllers (10.2%). After adjusting for potential confounders as sex, age, HIV transmission risk, CD4+ T-cell nadir and time of follow up, HCV clearance was independently associated with persistent HIV spontaneous control (p=0.002; OR (95% CI)= 2.573 (1.428-4.633), but not with transient spontaneous control (p=0.119; 1.589 (0.888-2.845). Furthermore, persistent HIV-controllers were more likely to spontaneously clear the HCV in comparison with transient controllers (p=0.027; 2.650 (1.119-6.276). Finally, no loss or a delayed time to lose HIV-controller status was independently associated with HCV spontaneous clearance (p= 0.010; 1.990 (1.177-3.364).
This study shows an association between spontaneous persistent HIV-control and HCV spontaneous clearance. Our results support common mechanisms involved in spontaneous persistent HIV control and HCV clearance. These results suggest persistent but not transient HIV-controllers as a good model of functional HIV cure.